Intensive care medicine
-
Intensive care medicine · Nov 1994
Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.
To study blood and bronchoalveolar lavage (BAL) fluid levels of platelet activating factor (PAF-acether) and phospholipase A2 (PLA2) in patients with septic shock or following severe trauma. ⋯ These results demonstrate a significant increase of both PLA2 and PAF-acether in the circulation of trauma patients, and a further increase in septic shock patients. It is possible that PAF-acether and PLA2 can be used as markers for the severity of the disease in septic shock and following severe trauma.
-
Intensive care medicine · Nov 1994
Clinical TrialA new device to remove obstruction from endotracheal tubes during mechanical ventilation in critically ill patients.
To evaluate the efficiency of a new device developed to remove obstructions from endotracheal tubes (ETT) in mechanically ventilated patients. ⋯ this experimental device can be safely and successfully used to remove obstructions from the ETT lumen, without suspending mechanical ventilation, reducing the need for rapid ETT substitution in emergency and life-threatening situations.